GOC News – Fall 2019

The GOC News

FALL 2019

The President’s Message

Dear colleagues, this is what happened in 2019

cancer and implications of HPV research and immunotherapy. The GOC Course on Molecular Biology focused on Hot Topics in Molecular Oncology. Next year will mark our 20th Annual CPD Meeting. Join us in celebrating this milestone! June rolled in and we were able to introduce GOC’s first ever Biennial Multivisceral Cytoreductive Cadaver Course at the Annual General Meeting (AGM) in Halifax, NS. The course included didactic lectures and hands- on cadaver lab sessions focussing on complex pelvic and upper abdominal procedures and led by a team of five surgeons including Dr. William Cliby, a gynecologic oncologist from the Mayo Clinic in Minnesota. This sold-out course was very successful. While in Halifax, we also had the chance to spend time with one of GOC’s founding fathers, Dr. Robert Fraser. Dr. Fraser served as GOC’s 4th president

from June 1987 to June 1989. He was instrumental in the development of the Division of Gynecologic Oncology in Halifax, the provincial cervical cancer prevention program, and the GTD registry. We were so happy to have him join our AGM in Halifax, he truly is an amazing man. At the AGM, we also celebrated Dr. Robert Lotocki, the recipient of the GOC’s Presidential Medal Award. For many of us, he exemplifies what it is to be a true academic gynecologic oncologist. We would like to thank him for his dedication throughout the years as a mentor, surgeon, and friend to many. 2020 will be a very special year for us as we reach the milestone of 40 years. We are currently planning a large gala celebration in June 2020 at our AGM.We are also excited to be having a full joint day which is the kick-off of the 10th

It is hard to believe that summer is over, and we are already well into the fall season! As we close off 2019, we have much to reflect on. 2019 was a great year for GOC and we are looking forward to next year when we celebrate our 40th anniversary as a society in Ottawa during our Annual General Meeting. We kicked off the year with the “Pan- Canadian Ovarian Cancer Practice Harmonization Initiative” meeting in February in Toronto. The objective of this phased-project is to develop and formalize pan-Canadian clinical practice recommendations aimed toward achieving optimization and harmonization of ovarian cancer

patient Various members of the Society were at the table to present, discuss, and vote on proposed consensus statements. The first manuscript is expected to be published in 2020. In May, we met again in Toronto for GOC’s 19th Annual Continuing Professional Development (CPD) Meeting. The theme was Gynecologic Oncology – At the Cutting Edge. Presentations included robotics in gynecologic oncology; the role of PARP inhibitors, the landscape of immunotherapy in Canada, successful immune-oncology program, advances in the treatment of cervix cancer, advances in the treatment of vulvar management.



03 CoP and Education Successes

04 GOC Members on the International Stage

09 Clinical Trials Update

Made with FlippingBook - professional solution for displaying marketing and sales documents online